Atai Life Sciences Debt to Equity Ratio 2020-2024 | ATAI
Current and historical debt to equity ratio values for Atai Life Sciences (ATAI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Atai Life Sciences debt/equity for the three months ending September 30, 2024 was 0.14.
| Atai Life Sciences Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2024-09-30 |
$0.05B |
$0.15B |
0.35 |
| 2024-06-30 |
$0.05B |
$0.17B |
0.28 |
| 2024-03-31 |
$0.05B |
$0.22B |
0.21 |
| 2023-12-31 |
$0.05B |
$0.24B |
0.20 |
| 2023-09-30 |
$0.04B |
$0.27B |
0.15 |
| 2023-06-30 |
$0.04B |
$0.22B |
0.18 |
| 2023-03-31 |
$0.04B |
$0.24B |
0.17 |
| 2022-12-31 |
$0.04B |
$0.27B |
0.15 |
| 2022-09-30 |
$0.05B |
$0.30B |
0.16 |
| 2022-06-30 |
$0.03B |
$0.32B |
0.09 |
| 2022-03-31 |
$0.03B |
$0.35B |
0.08 |
| 2021-12-31 |
$0.03B |
$0.39B |
0.07 |
| 2021-09-30 |
$0.02B |
$0.46B |
0.05 |
| 2021-06-30 |
$0.02B |
$0.49B |
0.04 |
| 2021-03-31 |
$0.03B |
$0.12B |
0.21 |
| 2020-12-31 |
$0.02B |
$0.10B |
0.17 |
| 2020-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2020-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2020-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2019-12-31 |
$0.00B |
$0.06B |
0.04 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.290B |
$0.000B |
|
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
|
